NHS Business Services Authority’s Drug Tariff Part IX Annual Review 2021-2022
A breakdown of the status of applications processed from May 2022
The purpose of this paper is to set out the advantages of a transparent, centrally negotiated and managed system where essential appliances (at the discretion ...
The Part IX Industry Drug Tariff Committee was formed in the early 1990s to represent companies supplying medical devices through prescription to the public, as ...
The Committee is comprised of representatives of all the relevant Trade Associations. Currently these are: ABHI (Association of British HealthTech Industry) BIVDA (British In-Vitro Diagnostics Association) BHTA (British Healthcare Trade Association) SDMA (Surgical ...